Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
Emory University
City of Hope Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Wisconsin, Madison
Dana-Farber Cancer Institute
NYU Langone Health
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
AGO Study Group
Dana-Farber Cancer Institute
Cooperative Weichteilsarkom Study Group
University Hospital Tuebingen